Company evidence record
The reviewed Companies House record identifies 9FIN LIMITED as an active UK private company. March 2026 filings record 2,372,086 new Series C preferred shares at £53.38309 each and authorise up to 139,527 existing ordinary shares for an Initial Secondary Sale, with completed transfers eligible for one-for-one redesignation into Series C preferred. The £7.45 million secondary value is only a same-price illustration: the filings do not disclose how many transfers completed, who sold or bought, or the price paid.
£126,629,280.43
Calculated primary subscription proceeds
2,372,086 Series C shares at £53.38309 each
139,527
Maximum authorised secondary shares
existing ordinary shares, subject to completed transfers
£7,448,382.40
Same-price secondary illustration
not disclosed transaction consideration
5.88%
Secondary ceiling versus primary share count
authorised shares divided by new Series C shares
Evidence library
The written resolutions creating the Series C class and setting the transfer, redesignation and pre-emption-waiver mechanics for the Initial Secondary Sale.
The Series C allotment filing recording the new-share count, per-share price and class particulars used to calculate primary subscription proceeds.
The 2025 group accounts supplying revenue, loss, operating cash-flow and year-end cash context before the Series C transaction.
Evidence boundary
Every finding stays tied to the reviewed documents. Transaction terms and ownership conclusions outside that record remain explicit limits.
The reviewed filings identify 9FIN LIMITED and company number 10451957, consistent with the active Companies House profile verified on 4 August 2026.
The 20 March 2026 allotment issued 2,372,086 new Series C preferred shares at £53.38309 each.
The March resolutions authorised up to 139,527 existing ordinary shares for the Initial Secondary Sale and allowed completed transfers to be redesignated one for one as Series C preferred shares after the required transfer evidence was delivered.
The filed 2025 group accounts report £31.4 million of revenue, a £21.09 million pre-tax loss, £11.71 million of operating cash outflow and £26.87 million of year-end cash.
The resolutions authorise a maximum secondary block but do not establish that all 139,527 shares completed transfer or that every transferred share was sold by an employee.
The £7.45 million figure applies the primary issue price to the authorised secondary ceiling; it is an illustration, not disclosed secondary consideration.
The member names in the resolutions are not a seller list, buyer list or current cap table, and the filings do not provide ownership percentages or fully diluted economics.
The public $170 million Series C headline is not interchangeable with the £126.63 million calculated from the UK allotment because currency, timing and transaction perimeter may differ.
Related analysis
9fin authorised 139,527 existing shares for its employee secondary, implying £7.45m at the Series C price before conversion into preferred stock.
Read the analysis